DNA amplification
In a study involving 1,300 blood samples from pregnant women, Myriad researchers demonstrated that their method could increase the fetal fraction for almost all.
Pacific Biosciences, Asuragen Collaborate on Clinical Assays
Asuragen will develop assays for PacBio's long-read next-generation sequencing systems, with an initial focus on developing a carrier screening assay.
Cue Health Closes $100M Series C Financing
The firm said that the proceeds will be used to complete the development of the Cue Health Monitoring System and Cue Test Cartridges.
NuProbe Licenses Two Oligonucleotide Technologies from Rice University
The technologies, called non-extensible oligonucleotides and linear DNA assembly, may help the sample prep firm improve existing products.
Pillar Biosciences Closes $29.7M Series C Financing Round
The cancer test developer will use the funding to commercialize its enrichment-based NGS panels. An IVD test also got CE marked.
Jan 23, 2020
Jan 8, 2020
BioSkryb Raises $11.5M in Seed Funding
Jul 25, 2019
Jul 10, 2018
Cue Health Closes $45M Series B Financing
Feb 12, 2018
DiaCarta Raises $45M in Series B Funding
Jun 24, 2016
May 13, 2015